Cartesian Therapeutics Inc (RNAC)
Cost of Revenue
$12.80M
TTM · Period ending: · USD
RNAC Cost of Revenue
Latest reported$12.80Mperiod ending
Latest reported$12.80Mperiod ending
RNAC TTM Cost of Revenue ($0.00 → $12.80M)
TTM cost of revenue
High-resolution chart · PNG
RNAC cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 12,797,000 | |
| 12,797,000 | |
| 12,797,000 | |
| 12,797,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 13,002,000 | |
| 30,784,000 | |
| 49,408,000 | |
| 50,015,000 | |
| 37,552,000 | |
| 20,268,000 | |
| 2,288,000 | |
| 1,681,000 | |
| 1,142,000 | |
| 644,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |